CMC Pharmaceuticals is a biopharma company in Ohio that develops new and improved drug formulations. Its filings show it lobbied Congress mainly on defense and budget matters, supporting Department of Defense funding and policies for chemical and biological medical countermeasures and matters tied to the Defense Appropriations and the National Defense Authorization Act. This activity was reported across four filings totaling $160,000.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DAVID JONES
The latest disclosures for this client.
CAPITOL COUNSEL LLC
Q2CAPITOL COUNSEL LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAPITOL COUNSEL LLC
LISA WHISLER
CAPITOL COUNSEL LLC
CAPITOL COUNSEL LLC
Q4CAPITOL COUNSEL LLC
Q3CAPITOL COUNSEL LLC
Q2CAPITOL COUNSEL LLC
Q1